Dermata Therapeutics: Dermata to Present at the H.C. Wainwri

SAN DIEGO, CA / ACCESSWIRE / January 5, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic

Related Keywords

California , United States , San Diego , Gerry Proehl , Sean Proehl , Hc Wainwright Bioconnect , Wendell Wierenga , Exchange Commission , Dermata Therapeutics Inc , Dermata Therapeutics , Nasdaq , Business Development , Chief Executive Officer , Bioconnect Virtual Conference , Investor Relations , Private Securities Litigation Reform Act , Dermata , Herapeutics , Present , Wainwright , Bioconnect , Conference ,